SCHEMBL21248843

SCHEMBL21248843

CC(C)(C)OC(=O)N[C@H]1CCN(c2c(C=O)cncc2-c2cccc(C#N)c2)C1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4D Q6B0I6 4/20 0.45
▸ CKS1B P61024 1/20 0.42
▸ SKP1 P63208 1/20 0.42
▸ SKP2 Q13309 1/20 0.42
▸ SUV39H2 Q9H5I1 4/20 0.42
▸ LRRK2 Q5S007 1/20 0.42
▸ RET P07949 2/20 0.41
▸ JAK3 P52333 1/20 0.41
▸ BTK Q06187 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ PIM3 Q86V86 1/20 0.41
▸ PIM2 Q9P1W9 1/20 0.41
▸ F2R P25116 1/20 0.41
▸ CTSK P43235 2/20 0.41
▸ SSTR5 P35346 1/20 0.40
▸ SYK P43405 1/20 0.40
▸ CCNC P24863 1/20 0.40
▸ CDK8 P49336 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21248845 1.00 KDM4D (0.45) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL21249063 0.89 SSTR5 (0.42) KDM4DSUV39H2RETJAK3BTK
SCHEMBL21248797 0.87 RET (0.46) KDM4DSUV39H2RETJAK3BTK
SCHEMBL21248799 0.87 RET (0.46) KDM4DSUV39H2RETJAK3BTK
SCHEMBL29653459 0.83 SYK (0.47) CKS1BSKP1SKP2SUV39H2JAK3
SCHEMBL21248860 0.81 SSTR5 (0.49) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL21249050 0.81 SSTR5 (0.57) SSTR5
SCHEMBL30477677 0.81 SSTR5 (0.49) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL21248718 0.80 RET (0.42) RETSSTR5
SCHEMBL21248719 0.80 RET (0.42) RETSSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752498-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2020-12-23 — — EP disclosed
WO-2019157458-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2019-08-15 — — WO disclosed
Send feedback